The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.
Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.
Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
And that’s a wrap on another great day of #EHA2021! @VJHemOnc are looking forward to listening to more tomorrow! Check the latest #EHA21 news 🔶https://tinyurl.com/VJHO-EHA21🔶 Don’t forget to register for tomorrow’s #VJSocial session at 7PM CEST👉 https://vjhemoncsocial.com/👈
Facilitating positive coping styles accounts for most of the effect from a palliative care intervention on improving QOL & depression symptoms in #AML Learn more from @tomleblancMD of @DukeCancer: http://ow.ly/itV150F4ISA #ASCO21 @ASCO #HemOnc #Leukemia #AMLsm #Leusm #QoL
#EHA2021 📢@gilles_salles opens the session on considerations for the evolving R/R DLBCL treatment landscape @VJHemOnc @EHA_Hematology #Lymsm #Lymphoma
Mark Levis of @KimmelCancerCtr talks on FF-10101-01 for R/R AML. Watch: 👉http://ow.ly/S8e550F85Zd👈 @EHA_Hematology #EHA2021 @VJHemOnc #HemOnc #Leusm #Leukemia #AMLsm
We are LIVE at the #VJSocial Masterclass 🙌 It’s your last chance to register for the ‘Trending in #Lymphoma’ #VJSocial Session ⏰ Join the conversation here 💥http://vjhemoncsocial.com💥 #EHA2021 #EHA21 #Lymsm #HemOnc #DLBCL
Explore our coverage of real-world data across a spectrum of hematological diseases.
The latest results from the key trials at ASH 2020.
Watch experts explain the data from cutting-edge research.
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter